JP2001502915A5 - - Google Patents

Download PDF

Info

Publication number
JP2001502915A5
JP2001502915A5 JP1998520526A JP52052698A JP2001502915A5 JP 2001502915 A5 JP2001502915 A5 JP 2001502915A5 JP 1998520526 A JP1998520526 A JP 1998520526A JP 52052698 A JP52052698 A JP 52052698A JP 2001502915 A5 JP2001502915 A5 JP 2001502915A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP1998520526A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001502915A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1997/018701 external-priority patent/WO1998018924A1/en
Publication of JP2001502915A publication Critical patent/JP2001502915A/ja
Publication of JP2001502915A5 publication Critical patent/JP2001502915A5/ja
Abandoned legal-status Critical Current

Links

JP10520526A 1996-10-25 1997-10-23 新規な幹細胞因子受容体アゴニストとしての環状に並べ替えたポリペプチド Abandoned JP2001502915A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2916596P 1996-10-25 1996-10-25
US60/029,165 1996-10-25
PCT/US1997/018701 WO1998018924A1 (en) 1996-10-25 1997-10-23 Circularly permuted polypeptides as novel stem cell factor receptor agonists

Publications (2)

Publication Number Publication Date
JP2001502915A JP2001502915A (ja) 2001-03-06
JP2001502915A5 true JP2001502915A5 (enExample) 2005-06-16

Family

ID=21847588

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10520526A Abandoned JP2001502915A (ja) 1996-10-25 1997-10-23 新規な幹細胞因子受容体アゴニストとしての環状に並べ替えたポリペプチド

Country Status (6)

Country Link
US (1) US5969105A (enExample)
EP (1) EP0941321A1 (enExample)
JP (1) JP2001502915A (enExample)
AU (1) AU734594B2 (enExample)
CA (1) CA2268023A1 (enExample)
WO (1) WO1998018924A1 (enExample)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6248319B1 (en) 1989-10-16 2001-06-19 Krisztina M. Zsebo Method for increasing hematopoietic progenitor cells by stem cell factor polypeptides
US6207454B1 (en) 1989-10-16 2001-03-27 Amgen Inc. Method for enhancing the effciency of gene transfer with stem cell factor (SCF) polypeptide
US6852313B1 (en) 1989-10-16 2005-02-08 Amgen Inc. Method of stimulating growth of melanocyte cells by administering stem cell factor
US7144731B2 (en) 1989-10-16 2006-12-05 Amgen Inc. SCF antibody compositions and methods of using the same
US5581476A (en) 1993-01-28 1996-12-03 Amgen Inc. Computer-based methods and articles of manufacture for preparing G-CSF analogs
AU778504B2 (en) * 1998-12-04 2004-12-09 Naval Medical Research Center Human brain endothelial cells and growth medium and method for expansion of primitive CD34+CD38- bone marrow stem cells
EP1228200A1 (en) * 1999-10-27 2002-08-07 California Institute Of Technology Production of functional hybrid genes and proteins
US6346247B1 (en) 1999-10-28 2002-02-12 Promega Corporation Prevention and treatment of autoimmune disease with luminally administered polyclonal antibodies
GB0024550D0 (enExample) 2000-10-06 2000-11-22 Oxford Biomedica Ltd
US7311905B2 (en) 2002-02-13 2007-12-25 Anthrogenesis Corporation Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
DK1349918T3 (da) 2000-12-06 2014-11-10 Anthrogenesis Corp Fremgangsmåde til indsamling af stamceller fra moderkagen
IL157350A0 (en) 2001-02-14 2004-02-19 Anthrogenesis Corp Post-partum mammalian placenta, its use and placental stem cells therefrom
WO2003006501A2 (en) 2001-07-11 2003-01-23 Maxygen Holdings, Ltd. G-csf conjugates
JP2006509770A (ja) 2002-11-26 2006-03-23 アンソロジェネシス コーポレーション 細胞治療学、細胞治療単位、およびそれらを利用した治療法
RU2007149238A (ru) 2005-06-01 2009-07-20 Максиджен Холдингз Лтд. (Ky) Пегилированные полипептиды гксф и способы их получения
AU2006304277B2 (en) 2005-10-13 2012-07-05 Celularity Inc. Immunomodulation using placental stem cells
US8455250B2 (en) 2005-12-29 2013-06-04 Anthrogenesis Corporation Co-culture of placental stem cells and stem cells from a second source
ES2671355T3 (es) 2005-12-29 2018-06-06 Anthrogenesis Corporation Poblaciones de células madre placentarias
SI2120977T1 (sl) 2007-02-12 2014-01-31 Anthrogenesis Coroporation Zdravljenje vnetnih bolezni z uporabo placentarnih matičnih celic
US9200253B1 (en) 2007-08-06 2015-12-01 Anthrogenesis Corporation Method of producing erythrocytes
RS53841B1 (sr) 2007-09-28 2015-06-30 Anthrogenesis Corporation Supresija tumora korišćenjem humanog placentalnog perfuzata i intermedijernih ćelija ubica poreklom iz humane placente
DK2330889T3 (en) 2008-08-20 2017-01-30 Anthrogenesis Corp Improved cell composition and process for making the same
KR20180108887A (ko) 2008-08-20 2018-10-04 안트로제네시스 코포레이션 단리된 태반 세포를 사용한 뇌졸중 치료
MX2011001992A (es) 2008-08-22 2011-03-29 Anthrogenesis Corp Metodos y composiciones para el tratamiento de defectos oseos con poblaciones de celulas placentarias.
CA2743566C (en) 2008-11-19 2021-11-09 Anthrogenesis Corporation Amnion derived adherent cells
AR077369A1 (es) 2009-07-02 2011-08-24 Anthrogenesis Corp Metodopara producir eritrocitos sin celulas alimentadoras
WO2011007348A2 (en) 2009-07-13 2011-01-20 Biogencell, Ltd. Method for using directing cells for specific stem/progenitor cell activation and differentiation
WO2011094181A1 (en) 2010-01-26 2011-08-04 Anthrogenesis Corporation Treatment of bone-related cancers using placental stem cells
SI2556145T1 (sl) 2010-04-07 2017-01-31 Anthrogenesis Corporation Angiogeneza z uporabo placentnih matičnih celic
AU2011237743A1 (en) 2010-04-08 2012-11-01 Anthrogenesis Corporation Treatment of sarcoidosis using placental stem cells
CN107828727A (zh) 2010-07-13 2018-03-23 人类起源公司 产生自然杀伤细胞的方法、由此获得的细胞群体及其用途
AR093183A1 (es) 2010-12-31 2015-05-27 Anthrogenesis Corp Aumento de la potencia de celulas madre de placenta usando moleculas de arn moduladoras
EP3443968A1 (en) 2011-06-01 2019-02-20 Celularity, Inc. Treatment of pain using placental stem cells
WO2013055476A1 (en) 2011-09-09 2013-04-18 Anthrogenesis Corporation Treatment of amyotrophic lateral sclerosis using placental stem cells
US8956870B2 (en) 2012-01-19 2015-02-17 Biogencell, Ltd. Method for using directing cells for specific stem/progenitor cell activation and differentiation
LT3401402T (lt) 2012-06-08 2020-12-28 Alkermes Pharma Ireland Limited Ligandai, modifikuoti cirkuliarinės permutacijos pagalba, kaip agonistai ir antagonistai
AU2014215458A1 (en) 2013-02-05 2015-08-13 Anthrogenesis Corporation Natural killer cells from placenta
WO2023145860A1 (ja) * 2022-01-27 2023-08-03 味の素株式会社 Scf受容体結合ペプチド

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2212411C2 (ru) * 1989-10-16 2003-09-20 Эмджен Инк. Полипептид, обладающий гемопоэтической биологической активностью фактора стволовых клеток (варианты), днк (варианты), экспрессирующий вектор (варианты), фармацевтическая композиция для гемопоэтической терапии, способ получения полипептида и способ его использования (варианты)
EP1241258A3 (en) * 1989-10-16 2003-12-10 Amgen Inc. Stem cell factor
US5635599A (en) * 1994-04-08 1997-06-03 The United States Of America As Represented By The Department Of Health And Human Services Fusion proteins comprising circularly permuted ligands
AU708755B2 (en) * 1994-11-04 1999-08-12 Merck Serono Sa Human SCF, a splice variant thereof its pharmaceutical use
PL184424B1 (pl) * 1995-10-05 2002-10-31 Searle & Co Agoniści krwiotwórczych receptorów wieloczynnościowych
US5885962A (en) * 1996-04-05 1999-03-23 Amgen Inc. Stem cell factor analog compositions and method

Similar Documents

Publication Publication Date Title
JP2002500524A5 (enExample)
JP2000502280A5 (enExample)
JP2000515996A5 (enExample)
JP2000501771A5 (enExample)
JP2000507471A5 (enExample)
JP2000501599A5 (enExample)
JP2000500076A5 (enExample)
JP2001504244A5 (enExample)
JP2001509188A5 (enExample)
JP2001505892A5 (enExample)
JP2000500055A5 (enExample)
JP2000500026A5 (enExample)
JP2000502472A5 (enExample)
JP2000501825A5 (enExample)
JP2000502425A5 (enExample)
JP2000502485A5 (enExample)
JP2000502568A5 (enExample)
JP2000501774A5 (enExample)
JP2000502570A5 (enExample)
JP2000501876A5 (enExample)
JP2001502915A5 (enExample)
JP2000501744A5 (enExample)
JP2000502316A5 (enExample)
JP2001508441A5 (enExample)
JP2000502714A5 (enExample)